Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
CTI BioPharma Corp. (CTIC)
NASDAQ:CTIC
CTI BioPharma (CTIC) Stock Price & Analysis
845 Followers
CTIC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.32 - $7.80
Previous Close$4.44
Volume530.71K
Average Volume (3M)3.02M
Market Cap
$586.01M
Enterprise Value$555.37M
Total Cash (Recent Filing)$79.94M
Total Debt (Recent Filing)$49.96M
Price to Earnings (P/E)-5.2
Beta0.20
Next Earnings
May 04, 2023EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding126,894,203
10 Day Avg. Volume2,131,701
30 Day Avg. Volume3,022,518
Standard Deviation0.31
R-Squared0.02
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-17.16
Price to Sales (P/S)21.20
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-6.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.29
Enterprise Value/Gross Profit11.01
Enterprise Value/Ebitda-7.22
Forecast
1Y Price Target
$11.30Price Target Upside154.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
CTI BioPharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTIC FAQ
What was CTI BioPharma Corp.’s price range in the past 12 months?
CTI BioPharma Corp. lowest stock price was $3.32 and its highest was $7.80 in the past 12 months.
What is CTI BioPharma Corp.’s market cap?
Currently, no data Available
When is CTI BioPharma Corp.’s upcoming earnings report date?
CTI BioPharma Corp.’s upcoming earnings report date is May 04, 2023 which is in 44 days.
How were CTI BioPharma Corp.’s earnings last quarter?
CTI BioPharma Corp. released its earnings results on Mar 06, 2023. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.096 by -$0.044.
Is CTI BioPharma Corp. overvalued?
According to Wall Street analysts CTI BioPharma Corp.’s price is currently Undervalued.
Does CTI BioPharma Corp. pay dividends?
CTI BioPharma Corp. does not currently pay dividends.
What is CTI BioPharma Corp.’s EPS estimate?
CTI BioPharma Corp.’s EPS estimate is -$0.1.
How many shares outstanding does CTI BioPharma Corp. have?
CTI BioPharma Corp. has 131,835,890 shares outstanding.
What happened to CTI BioPharma Corp.’s price movement after its last earnings report?
CTI BioPharma Corp. reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.096. Following the earnings report the stock price went down -10.223%.
Which hedge fund is a major shareholder of CTI BioPharma Corp.?
Among the largest hedge funds holding CTI BioPharma Corp.’s share is Perceptive Advisors LLC. It holds CTI BioPharma Corp.’s shares valued at N/A.
---
CTI BioPharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.30 (154.22% Upside)
$11.30 (154.22% Upside)
Blogger Sentiment
Neutral
CTIC Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.8%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Very Negative
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
73.85%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CTI BioPharma Corp.
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
---
---